What do systematic reviews say?

Azithromycin vs erythromycin

Azithromycin showed no clear difference in microbiological cure compared with erythromycin (moderate certainty).

• Interventions for treating genital Chlamydia trachomatis infection in pregnancy 2017 · Cochrane Headline outcomes only
  RR 1.11 [1, 1.23]
  6 studies · 374 participants
  Moderate

Clindamycin vs erythromycin

Clindamycin showed no clear difference in microbiological cure compared with erythromycin (low certainty).

• Interventions for treating genital Chlamydia trachomatis infection in pregnancy 2017 · Cochrane Headline outcomes only
  RR 1.06 [0.97, 1.15]
  2 studies · 173 participants
  Low

Amoxicillin vs clindamycin

Amoxicillin showed no clear difference in microbiological cure compared with clindamycin (moderate certainty).

• Interventions for treating genital Chlamydia trachomatis infection in pregnancy 2017 · Cochrane Headline outcomes only
  RR 0.96 [0.89, 1.04]
  1 study · 101 participants
  Moderate

Lifestyle vs control ‐ Neonatal and later outcomes

It is very uncertain whether lifestyle changes composite outcome in infant (death, shoulder dystocia, nerve palsy,… compared with control ‐ Neonatal and later outcomes (very low certainty).

• Lifestyle interventions for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes only
  RR 0.57 [0.21, 1.55]
  2 studies · 1930 participants
  Very low

Lifestyle vs control ‐ Neonatal and later outcomes

Lifestyle showed no clear difference in neonatal hypoglycaemia compared with control ‐ Neonatal and later outcomes (moderate certainty).

• Lifestyle interventions for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes only
  RR 0.99 [0.65, 1.52]
  6 studies · 3000 participants
  Moderate

Lifestyle vs control ‐ Neonatal and later outcomes

• Lifestyle interventions for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 958 participants
  Low

Lifestyle vs control ‐ Neonatal and later outcomes

Lifestyle showed no clear difference in adiposity (child) ‐ Childhood BMI > 85th percentile compared with control ‐ Neonatal and later outcomes (moderate certainty).

• Lifestyle interventions for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes only
  RR 0.91 [0.75, 1.11]
  3 studies · 767 participants
  Moderate

Lifestyle vs control ‐ Neonatal and later outcomes

The review found no eligible studies for this question.

• Lifestyle interventions for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lifestyle vs control ‐ Neonatal and later outcomes

The review found no eligible studies for this question.

• Lifestyle interventions for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lifestyle vs control ‐ Neonatal and later outcomes

The review found no eligible studies for this question.

• Lifestyle interventions for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lifestyle vs control ‐ Neonatal and later outcomes

The review found no eligible studies for this question.

• Lifestyle interventions for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lifestyle vs control ‐ Neonatal and later outcomes

The review found no eligible studies for this question.

• Lifestyle interventions for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lifestyle vs control ‐ Neonatal and later outcomes

Lifestyle showed no clear difference in perinatal (fetal and neonatal death) and later infant mortality compared with control ‐ Neonatal and later outcomes (low certainty).

• Lifestyle interventions for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes only
  RR 0.09 [0.01, 1.7]
  2 studies · 1988 participants
  Low

Acupuncture vs placebo

It is very uncertain whether acupuncture changes quality of life: anxiodepressive symptomatology compared with placebo (very low certainty).

• Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
  RR 1.01 [0.73, 1.4]
  1 study · 36 participants
  Very low

Pyridoxine vs placebo

• Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 92 participants
  Moderate

Pyridoxine vs placebo

The review found no eligible studies for this question.

• Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Metoclopramide vs ondansetron

• Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 83 participants
  Very low

Metoclopramide vs ondansetron

• Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 83 participants
  Very low

Metoclopramide vs ondansetron

• Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 160 participants
  Moderate

Acupuncture vs placebo

Acupuncture showed no clear difference in spontaneous abortion compared with placebo (low certainty).

• Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
  RR 0.48 [0.05, 5.03]
  1 study · 57 participants
  Low